Picat MA - Search Results

Year	Number of Results
2011	1
2012	1
2015	2
2016	1
2017	5
2018	5
2019	2
2020	3
2021	4
2022	8
2023	9
2024	5

1

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group. Andrieu S, et al. Lancet Neurol. 2017 May;16(5):377-389. doi: 10.1016/S1474-4422(17)30040-6. Epub 2017 Mar 27. Lancet Neurol. 2017. PMID: 28359749 Clinical Trial.

2

Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment.

Lehmann S, Schraen-Maschke S, Vidal JS, Delaby C, Buee L, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Hanon O; BALTAZAR study group. Lehmann S, et al. J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1046-1053. doi: 10.1136/jnnp-2024-333467. J Neurol Neurosurg Psychiatry. 2024. PMID: 38658136 Free PMC article.

3

Investigating three ways of measuring the intrinsic capacity domain of vitality: nutritional status, handgrip strength and ageing biomarkers.

Lu WH, González-Bautista E, Guyonnet S, Martinez LO, Lucas A, Parini A, Rolland Y, Vellas B, de Souto Barreto P; MAPT/DSA Group. Lu WH, et al. Age Ageing. 2023 Jul 1;52(7):afad133. doi: 10.1093/ageing/afad133. Age Ageing. 2023. PMID: 37505993

4

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial.

Delrieu J, Vellas B, Guyonnet S, Cantet C, Ovod V, Li Y, Bollinger J, Bateman R, Andrieu S; MAPT/DSA group. Delrieu J, et al. Alzheimers Res Ther. 2023 Oct 23;15(1):183. doi: 10.1186/s13195-023-01325-3. Alzheimers Res Ther. 2023. PMID: 37872582 Free PMC article. Clinical Trial.

5

Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study.

Blum D, Cailliau E, Béhal H, Vidal JS, Delaby C, Buée L, Allinquant B, Gabelle A, Bombois S, Lehmann S, Schraen-Maschke S, Hanon O; BALTAZAR study group. Blum D, et al. Alzheimers Dement. 2024 Oct;20(10):6948-6959. doi: 10.1002/alz.14169. Epub 2024 Aug 4. Alzheimers Dement. 2024. PMID: 39099181 Free PMC article.

6

Association between urate-lowering therapies and cognitive decline in community-dwelling older adults.

Molet-Benhamou L, Giudici KV, de Souto Barreto P, Cantet C, Rolland Y; MAPT/DSA group. Molet-Benhamou L, et al. Sci Rep. 2022 Sep 12;12(1):15299. doi: 10.1038/s41598-022-17808-6. Sci Rep. 2022. PMID: 36097005 Free PMC article. Clinical Trial.

7

Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial.

Coley N, Zetterberg H, Cantet C, Guyonnet S, Ashton NJ, Vellas B, Blennow K, Andrieu S; MAPT study group. Coley N, et al. Lancet Healthy Longev. 2024 Feb;5(2):e120-e130. doi: 10.1016/S2666-7568(23)00255-6. Lancet Healthy Longev. 2024. PMID: 38310892 Free article.

8

Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia.

Lehmann S, Schraen-Maschke S, Vidal JS, Delaby C, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Hanon O; The BALTAZAR Study Group. Lehmann S, et al. Clin Chem. 2023 Sep 1;69(9):1072-1083. doi: 10.1093/clinchem/hvad103. Clin Chem. 2023. PMID: 37654065

9

Association between physical activity, growth differentiation factor 15 and bodyweight in older adults: A longitudinal mediation analysis.

Raffin J, Rolland Y, Parini A, Lucas A, Guyonnet S, Vellas B, de Souto Barreto P; MAPT/DSA Group. Raffin J, et al. J Cachexia Sarcopenia Muscle. 2023 Jan 20;14(2):771-80. doi: 10.1002/jcsm.13152. Online ahead of print. J Cachexia Sarcopenia Muscle. 2023. PMID: 36999490 Free PMC article.

10

Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.

Sanchez-Sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, Parini A, Vellas B, de Souto Barreto P; MAPT/DSA Group. Sanchez-Sanchez JL, et al. Alzheimers Res Ther. 2022 Jan 7;14(1):5. doi: 10.1186/s13195-021-00940-2. Alzheimers Res Ther. 2022. PMID: 34996522 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year